Bodhi Tree Biotechnology Inc (BDTB) stock

BDTBOTCServices-Management Consulting ServicesFiscal year ends September 30

Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026

$0.28+0.00 (0.00%)

Close on Oct 19, 2026Market cap $7.17MP/E –Yield –

Bodhi Tree Biotechnology statistics

27 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: –
Last ex-dividend date: No dividends
Fundamentals through: Jun 30, 2026
Share price as of: –

Share statisticsIndustry

Shares Outstanding: 25M; 28M
Shares Change (QoQ): 0.00%; 0.00%
Float: 25M; 27M
Shares Held by Insiders: 0.00%; 4.27%

MarginsIndustry

Operating Margin: -310.2%; 1.24%
Pretax Margin: -310.2%; 2.70%
Profit Margin: -313.6%; 0.84%
EBITDA Margin: -310.2%; 3.79%

Returns on capitalIndustry

Return on Equity (ROE): -161.5%; 1.76%
Return on Assets (ROA): -156.6%; -2.60%
Return on Invested Capital (ROIC): -899.0%; 5.25%
Return on Capital Employed (ROCE): -830.2%; 3.71%

Financial positionIndustry

Quick Ratio: 0.89; 0.75

EfficiencyIndustry

Asset Turnover: 0.50; 0.82

Income statement (TTM)Industry

Revenue: $37.00K; $23.08M
Operating Income: -$114.77K; -$48.83K
Pretax Income: -$114.76K; -$31.25K
Net Income: -$116.03K; -$62.45K
EBITDA: -$114.77K; -$25.17K
EPS (Diluted): -$0.01; $0.00

Balance sheetIndustry

Cash & Short-Term Investments: $3.99K; $5.19M
Net Cash (Debt): $3.99K; $15.49K
Net Cash Per Share: $0.00; $0.00
Equity (Book Value): $13.82K; $10.55M
Book Value Per Share: $0.00; $0.73
Tangible Book Value: $13.82K; $13.82K

Cash flow (TTM)Industry

Operating Cash Flow: -$115.53K; $41.37K

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.

Period	BDTB	S&P 500	Difference	BDTB per year	S&P 500 per year
1 month	+41.0%	+0.6%	+40.4 pts
3 months	+41.0%	+3.4%	+37.6 pts

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

Where these numbers come from

Parsed from the XBRL in Bodhi Tree Biotechnology's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is BDTB.

Compare: BDTB vs HSTA · BDTB vs YSGL · BDTB vs RDSC · BDTB vs HAMVF · BDTB vs PHCI

Operating margin-310.2% · median -1427.6%

Net margin-313.6% · median -974.4%

Company	Revenue	Growth
PHCI	$188.53K	-11.1%
RDSC	$44.53K	–
YSGL	$43.17K	–
BDTB	$37.00K	–
HSTA	$24.00K	–
HAMVF	–	–

Company

Exchange: OTC
Industry: Services-Management Consulting Services
Fiscal year ends: September 30
Auditor: Simon & Edward, LLP
SEC CIK: 2041531

Advertisement
300 × 250

See a number that looks wrong?